1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sapropterin in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sapropterin) | Trials (sapropterin) | Recent Studies (post-2010) (sapropterin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 2,362 | 93 | 614 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caplan, MS; De Plaen, IG; Hsueh, W; Qu, XW; Rozenfeld, RA; Thaete, LG; Zhu, Y | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sapropterin
Article | Year |
---|---|
Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase.
Topics: Animals; Antioxidants; Biopterins; Enzyme Inhibitors; Indazoles; Intestinal Diseases; Male; Nerve Tissue Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Platelet Activating Factor; Pterins; Rats; Rats, Sprague-Dawley; Splanchnic Circulation | 2005 |